Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell TJX Companies Inc (TJX) – TJX Companies Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

AI boosts pharmaceutical packaging quality, cutting defects and costs with fast ROI and regulatory compliance.

AI technology is revolutionizing pharmaceutical packaging by enabling zero-defect production and meeting strict regulatory standards. Automated AI inspection systems deliver a 315% ROI with payback under four months, improve throughput by 32%, and re...

Market News
18 minutes ago
Bcc Research
Bullish
news icon
pluang ai news

Anthropic's Mythos AI uncovers thousands of security flaws, sparking urgent financial sector warnings.

Anthropic developed Mythos, an AI model that identifies thousands of long-standing security vulnerabilities across major software platforms, prompting the company to restrict its release. This discovery led to an emergency meeting with US financial l...

Market News
24 minutes ago
Opeyemi Babalola
Bullish
news icon
pluang ai news

Barrel Energy becomes fully SEC reporting, boosting growth and market visibility in renewables and nutrition energy.

Barrel Energy Inc. has achieved full reporting status with the U.S. Securities and Exchange Commission, marking a key milestone in its growth strategy. This status enhances the company's transparency and marketability, allowing it to attract more inv...

Market News
27 minutes ago
Prnewswire
Bullish
news icon
pluang ai news

FDA expands approval for Argenx's VYVGART to treat all adult generalized myasthenia gravis patients.

The FDA has approved an expanded label for Argenx's drug VYVGART, allowing its use for all adult patients with generalized myasthenia gravis (gMG), including all serotypes. This broadens the patient pool significantly and supports Argenx's growth str...

Market News
40 minutes ago
Vandana Singh
Bullish
news icon
pluang ai news

Personalized medicine market to exceed $1 trillion by 2034, driven by genomics and AI advances.

The personalized medicine market is projected to grow from USD 524 billion in 2025 to over USD 1 trillion by 2034, fueled by advances in genomics, biomarker diagnostics, and AI-powered data analytics. This growth is driven by rising chronic diseases ...

Market News
1 hour ago
Delveinsight
Bullish
news icon
pluang ai news

Presbyopia market to grow at 4.9% CAGR by 2036, driven by aging population and new treatments.

The global presbyopia market is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2036, fueled by the increasing aging population and rising prevalence of near vision impairment. Market expansion is supported by greater a...

Market News
1 hour ago
Delveinsight
Bullish
news icon
pluang ai news

New report details Diageo's financials, SWOT, and market position in Food & Beverages industry

ResearchAndMarkets.com released a comprehensive report on Diageo plc covering its financial performance, SWOT analysis, competitive landscape, and industry position. The report highlights Diageo's strengths like its strong brand portfolio and financi...

Market News
3 hours ago
Researchandmarkets.Com
Neutral
pluang ai news

Lecanemab injection market to grow to $6.63B by 2030, driven by early Alzheimer's diagnosis and aging population

The global lecanemab injection market is projected to grow from $3.07 billion in 2026 to $6.63 billion by 2030, fueled by increased early-stage Alzheimer's diagnosis, FDA approvals, and expanded reimbursement policies. This growth is supported by inn...

Market News
3 hours ago
Researchandmarkets.Com
Bullish
news icon
pluang ai news

Nvidia shifts from chipmaker to AI industry leader with strong growth and investment strategy.

Nvidia is transforming from a traditional semiconductor maker into a key architect of the AI industry by strategically investing across the entire AI value chain. The company focuses on expanding AI computing capacity, resolving supply chain issues, ...

Analyst Insights
4 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news

Law firm investigates GeneDX for possible securities violations after stock drops 45% on weak revenue guidance

Block & Leviton is investigating GeneDX Holdings Corp. for potential securities law violations following a sharp 45% drop in its stock price after the company reported first quarter revenue below expectations and lowered its 2026 revenue guidance. Th...

Market News
4 hours ago
Newsfile Corp
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $169.59B
  • Sector
    Consumer Cyclical
  • 3M Drawdown
    -7.05%
  • Enterprise Value
    $176.85B
  • Dividend Yield
    1.25%
  • Trading Activity
    15% Buy | 85% Sell
  • Typical Hold Time
    93 days
$147.37
52W Low: $121.35
16 Jul 2025
52W High: $165
09 Apr 2026

TJX Companies Inc (TJX) is currently valued at a market capitalization of $169.59B, with an enterprise value of $176.85B. Over the past 52 weeks, TJX Companies Inc has traded between a low of $121.35 and a high of $165, highlighting its annual price range. Over the past three months, TJX Companies Inc has recorded a drawdown of -7.05%, reflecting recent price volatility. TJX Companies Inc offers a dividend yield of 1.25%, with the most recent dividend of $0.43 paid on 12 Feb 26. On average, investors hold TJX Companies Inc for approximately 93 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!